Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for masticatory muscle hyperactivity in cerebral palsy
2012-004795-19Phase 3Active
- Sponsor
- Folktandvården Västra Götaland
- Start
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of botulinum toxin type A in bruxism, Masticatory muscle hyperactivity (MMH) and cerebral palsy (CP) (2 arms), sponsored by Folktandvården Västra Götaland. Primary endpoint: Bite force reduction. Started Dec 2012; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
bruxismMasticatory muscle hyperactivity (MMH)cerebral palsy (CP)
Beyond the preview
Go deeper on 2012-004795-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004795-19.